Bethlehem, R.A.I., Seidlitz, J., White, S.R. et al. Brain charts for the human lifespan. Nature 604, 525–533 (2022). https://doi.org/10.1038/s41586-022-04554-y
Deng, Y. (2024). Small-Molecular Drugs for Alzheimer’s Disease. Transactions on Materials, Biotechnology and Life Sciences, 7, 328–334. https://doi.org/10.62051/6w0z4432
Diederich, N. J., & Goetz, C. G. (2024). Parkinson’s Disease. 205–227. https://doi.org/10.1093/med/9780197676592.003.0010
FallahBagheri, N., & Akan, Ö. B. (2024). A Molecular Communication Perspective of Alzheimer’s Disease: Impact of Amyloid Beta Oligomers on Glutamate Diffusion in the Synaptic Cleft. https://doi.org/10.48550/arxiv.2409.03396
Mete, A., Gedikbaşı, A., Yediel, B. Ş., Konukoğlu, D., Kırbaş, D., Gezen‐Ak, D., Dursun, E., Ercan, M., Alaylıoğlu, M., Geçin, M. N., Bolayırlı, M., Boz, C., Bozluolçay, M., Çamoğlu, T., Çevik, F. E., İlhan, N., Güleç, Z. E. K., Kücür, M., Oruç, A., … Yılmaz, H. (2024). Alzheimer’s Disease: From Molecular Mechanisms to Clinical Practices. https://doi.org/10.69860/nobel.9786053359166
Tong, J. (2024). The pathogenesis and treatment of Parkinson’s disease. Theoretical and Natural Science, 47(1), 15–19. https://doi.org/10.54254/2753-8818/47/2024pj0101
Priyanka, H. P., & Nair, R. S. (2020). Neuroimmunomodulation by estrogen in health and disease. AIMS neuroscience, 7(4), 401–417. https://doi.org/10.3934/Neuroscience.2020025
Yang, H. S., Zhang, C., Carlyle, B. C., Zhen, S. Y., Trombetta, B. A., Schultz, A. P., Pruzin, J. J., Fitzpatrick, C. D., Yau, W. W., Kirn, D. R., Rentz, D. M., Arnold, S. E., Johnson, K. A., Sperling, R. A., Chhatwal, J. P., & Tanzi, R. E. (2022). Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimer’s & dementia : the journal of the Alzheimer’s Association, 18(4), 645–653. https://doi.org/10.1002/alz.12399